Sandoz launches generic Augmentin XR
PRINCETON, N.J. Sandoz has launched a generic antibiotic for pneumonia and acute sinus infections, the generics arm of Swiss drug maker Novartis said Tuesday.
Sandoz said it launched amoxicillin and clavulanate potassium extended-release tablets, a generic version of GlaxoSmithKline’s Augmentin XR, in the 1,000-mg/62.5-mg strengths. The tablets are used to treat community-acquired pneumonia and acute bacterial sinusitis. Sandoz said it was the first company to file a regulatory approval application for the drug with the Food and Drug Administration, entitling it to six months’ market exclusivity.
Augmentin XR had sales of $53 million during the 12-month period ending in January, according to IMS Health.